Trial intelligence / Profile preview

ShouTai Pills for Diminished Ovarian Reserve

NCT07737847Not yet recruiting

Sponsor
Peking Union Medical College Hospital
Start
Oct 2026
Primary completion
Jun 2028
Countries
1
01

Overview

Randomised trial of Shoutai Pill in Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Number of Metaphase II oocytes at 3 months. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

Shoutai Pill
03

Conditions

Diminished Ovarian Reserve (DOR)

Beyond the preview

Go deeper on NCT07737847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07737847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call